Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection
- PMID: 16495535
- PMCID: PMC1418675
- DOI: 10.1128/IAI.74.3.1643-1648.2006
Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection
Abstract
It is thought that Trypanosoma cruzi, the protozoan that causes Chagas' disease, modulates the extracellular matrix network to facilitate infection of human cells. However, direct evidence to document this phenomenon is lacking. Here we show that the T. cruzi gp83 ligand, a cell surface trans-sialidase-like molecule that the parasite uses to attach to host cells, increases the level of laminin gamma-1 transcript and its expression in mammalian cells, leading to an increase in cellular infection. Stable RNA interference (RNAi) with host cell laminin gamma-1 knocks down the levels of laminin gamma-1 transcript and protein expression in mammalian cells, causing a dramatic reduction in cellular infection by T. cruzi. Thus, host laminin gamma-1, which is regulated by the parasite, plays a crucial role in the early process of infection. This is the first report showing that knocking down the expression of a human gene by RNAi inhibits the infection of an intracellular parasite.
Figures





Similar articles
-
Stable RNA interference of host thrombospondin-1 blocks Trypanosoma cruzi infection.FEBS Lett. 2006 Apr 17;580(9):2365-70. doi: 10.1016/j.febslet.2006.03.054. FEBS Lett. 2006. PMID: 16616140
-
Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host.Parasitology. 1994;108 Suppl:S37-44. doi: 10.1017/s0031182000075703. Parasitology. 1994. PMID: 8084653 Review.
-
A conserved domain of the gp85/trans-sialidase family activates host cell extracellular signal-regulated kinase and facilitates Trypanosoma cruzi infection.Exp Cell Res. 2007 Jan 1;313(1):210-8. doi: 10.1016/j.yexcr.2006.10.008. Epub 2006 Oct 17. Exp Cell Res. 2007. PMID: 17101128
-
Trypanosoma cruzi Binds to Cytokeratin through Conserved Peptide Motifs Found in the Laminin-G-Like Domain of the gp85/Trans-sialidase Proteins.PLoS Negl Trop Dis. 2015 Sep 23;9(9):e0004099. doi: 10.1371/journal.pntd.0004099. eCollection 2015 Sep. PLoS Negl Trop Dis. 2015. PMID: 26398185 Free PMC article.
-
The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.Glycobiology. 2015 Nov;25(11):1142-9. doi: 10.1093/glycob/cwv057. Epub 2015 Jul 29. Glycobiology. 2015. PMID: 26224786 Review.
Cited by
-
Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.Front Immunol. 2012 Nov 6;3:337. doi: 10.3389/fimmu.2012.00337. eCollection 2012. Front Immunol. 2012. PMID: 23133440 Free PMC article.
-
MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.J Biol Chem. 2013 Aug 30;288(35):25414-25427. doi: 10.1074/jbc.M113.460287. Epub 2013 Jul 12. J Biol Chem. 2013. PMID: 23853098 Free PMC article.
-
Perspectives on the Trypanosoma cruzi-host cell receptor interactions.Parasitol Res. 2009 Jun;104(6):1251-60. doi: 10.1007/s00436-009-1383-3. Epub 2009 Mar 13. Parasitol Res. 2009. PMID: 19283409 Free PMC article. Review.
-
Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.PLoS One. 2012;7(7):e40614. doi: 10.1371/journal.pone.0040614. Epub 2012 Jul 11. PLoS One. 2012. PMID: 22808206 Free PMC article.
-
Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.Chem Biodivers. 2010 May;7(5):1051-64. doi: 10.1002/cbdv.200900320. Chem Biodivers. 2010. PMID: 20491065 Free PMC article.
References
-
- Avalos, S. V., I. J. Blader, M. Fischer, J. C. Boothroyd, and B. A. Burleigh. 2002. Immediate early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:639-644. - PubMed
-
- Blohm, D. H., and A. Guiseppi-Elie. 2001. New developments in microarray technology. Curr. Opin. Biotechnol. 12:41-47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 HL007737/HL/NHLBI NIH HHS/United States
- MD 000104/MD/NIMHD NIH HHS/United States
- HL 007737/HL/NHLBI NIH HHS/United States
- GM 059994/GM/NIGMS NIH HHS/United States
- G12 RR003032/RR/NCRR NIH HHS/United States
- GM 08037/GM/NIGMS NIH HHS/United States
- RR 003032/RR/NCRR NIH HHS/United States
- S21 MD000104/MD/NIMHD NIH HHS/United States
- S06 GM008037/GM/NIGMS NIH HHS/United States
- T32 AI007281/AI/NIAID NIH HHS/United States
- F31 AI056667/AI/NIAID NIH HHS/United States
- R25 GM059994/GM/NIGMS NIH HHS/United States
- AI 056667/AI/NIAID NIH HHS/United States
- AI 07281/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources